A wearable wrist tracker to detect COVID-19 symptoms at an early stage will be available in the market next month with its developer, an IIT Madras incubated start-up, raising funding of Rs 22 crore for the purpose.
“Muse wearables”, the start-up incubated at IIT Madras by an alumni group along with an NIT Warangal alumnus, is planning to launch the trackers in 70 countries.
The wrist-based tracker has sensors for skin temperature, heart rate and SpO2 (blood oxygen saturation) which can continuously track these body vitals remotely to help in early diagnosis of COVID-19 symptoms.
The tracker will be Bluetooth-enabled and can be connected to the mobile phone via an app called the Muse Health App. The user vitals and activity data are stored on the phone as well as a remote server. Administrative access can also be provided for centralized monitoring of people in containment areas for COVID-19 symptoms.
Elegant Themes - The most popular WordPress theme in the world and the ultimate WordPress Page Builder. Get a 30-day money-back guarantee. Get it for Free
The tracker can get notifications from the Arogya Setu app and alert the user when she enters a COVID containment zone.
Users can raise an Emergency Alert (SOS) in case of any difficulty and the alert is raised when body temperature is higher than the threshold. The app also alerts people when SpO2 levels are too low or when the user is entering into a COVID containment area.
“We are targeting two lakh product sales this year with plans to achieve 10 lakh product sales by 2022 across the world. The investors believe in our innovations and believe that we can create a huge difference in the consumer tech space and we have been able to generate funding of Rs 22 crore,” KLN Sai Prasanth, an IIT Madras alumni.
Priced at around Rs 3500, the new wearable product will be available in the market for consumers across 70 countries by August.
K Prathyusha, an NIT Warangal graduate, said, “Our main objective with this product is to facilitate identification of patients who have COVID pneumonia sooner so that they can be treated more effectively.”
“We have developed algorithms to estimate body temperature from the skin and ambient temperature, heart rate and motion sensing.
“With continuous temperature and SpO2 monitoring, we will be able to detect silent hypoxia (an early symptom of coronavirus infection even in asymptomatic patients) at an early stage. This will also help the general public for proactive health monitoring along with fitness tracking and sleep tracking,” Prathyusha said.